| 2026-08-12 | Press release | Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission |
| 2026-08-10 | Press release | Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 |
| 2026-08-04 | Press release | Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mappin |
| 2026-07-24 | Press release | Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study |
| 2026-07-23 | Press release | Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform |
| 2026-07-15 | Press release | Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform |
| 2026-07-13 | Press release | Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant |
| 2026-07-13 | Press release | Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules |
| 2026-06-18 | Press release | Autonomix Announces Reverse Stock Split |
| 2026-06-10 | Press release | Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of |
| 2026-06-04 | Press release | Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor |
| 2026-05-19 | Press release | Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural |
| 2026-05-19 | Press release | Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural |
| 2026-05-19 | Press release | Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural |
| 2026-05-19 | Press release | Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural |
| 2026-05-19 | Press release | Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural |
| 2026-05-18 | Press release | Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mit |
| 2026-04-29 | Press release | Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic C |
| 2026-04-22 | Press release | Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026 |
| 2026-04-08 | Press release | Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Canc |
| 2026-03-11 | Press release | Autonomix Medical to Present at LSI USA '26 |
| 2026-03-05 | Press release | Autonomix Medical Selected for Best Innovation Competition at CRT 2026 |
| 2026-03-04 | Press release | Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and |
| 2026-02-25 | Press release | Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validatio |
| 2026-02-19 | Press release | Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting |
| 2026-01-28 | Press release | Autonomix Medical to Present Final Analysis on Pain Mitigation in Pancreatic Cancer at SIO 2026 Annual Scientific Meetin |
| 2026-01-09 | Press release | Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages o |
| 2025-12-23 | Press release | Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtu |
| 2025-12-18 | Press release | Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Onc |
| 2025-11-26 | Press release | Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution |
| 2025-11-18 | Press release | Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced At The Market Under Nasdaq Rules |
| 2025-11-17 | Press release | Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from P |
| 2025-10-24 | Press release | Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcathete |
| 2025-10-16 | Press release | Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit |
| 2025-10-02 | Press release | Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment |
| 2025-09-29 | Press release | Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System |
| 2025-09-09 | Press release | Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual Congress |
| 2025-09-04 | Press release | Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment |
| 2025-09-03 | Press release | Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer- |
| 2025-09-02 | Press release | Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference |